Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Diagnostic and Biopsy/Referral Sensitivity to Melanoma Between Three Groups of Physicians and MelaFind

NCT01011153 is registered in ClinicalTrials.gov with MELA Sciences, Inc. as lead sponsor.

NCT NCT01011153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01011153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Diagnostic and Biopsy/Referral Sensitivity to Melanoma Between Three Groups of Physicians and MelaFind
Lead sponsor
MELA Sciences, Inc.
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
February 28, 2010
Enrollment
241 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma